Lincoln Pharma’s revenue marginally rose by 1.4% to ₹163.4 crore from ₹161.2 crore in the base quarter. Previous Post Sky Gold Q2 Results: Stock gains 4% after earnings, then falls 8% from the highs Next Post Exclusive | Emirates NBD in race for IDBI Bank acquisition despite RBL Bank deal Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
